Indomethacin reduces lung adenoma number in A/J mice

Citation
Tw. Moody et al., Indomethacin reduces lung adenoma number in A/J mice, ANTICANC R, 21(3B), 2001, pp. 1749-1755
Citations number
48
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
21
Issue
3B
Year of publication
2001
Pages
1749 - 1755
Database
ISI
SICI code
0250-7005(200105/06)21:3B<1749:IRLANI>2.0.ZU;2-T
Abstract
The effects of indomethacin on A/J mice were investigated. The non-steroida l antiinflammatory drug (NSAID) indomethacin reduced significantly the numb er of lung adenomas 3, 4 or 8 months after urethane injection by 28, 30 and 29% respectively. The density of apoptotic cell bodies increased 2.9-fold in the lung adenomas of A/J mice treated with indomethacin. By immunocytoch emistry, COX-2 immunoreactivity was present in the cytosol of lung adenomas , and in epithelial cells lining the bronchioli and bronchus as well as typ e 2 alveolar cells. COX-1 immunostaining was similar to that of COX-2 in th e lungs of urethane-injected mice treated with or without indomethacin. By RT-PCR, COX-1 and COX-2 PCR products were present in mouse hung adenomas; a lveoli and bronchioli. These results suggest that indomethacin may inhibit COX-1 and COX-2 in the A/J mouse lung resulting in reduced adenoma formatio n.